{"article_title": "Abbott Labs Reports 44% Profit Decline", "article_keywords": ["billion", "decline", "abbott", "weakened", "profit", "rose", "44", "share", "sales", "reports", "labs", "cents", "yearearlier", "quarter", "continued", "struggle"], "article_url": "http://www.wsj.com/articles/SB10001424052702303947904579336382486580134", "article_text": "Abbott Laboratories continued to struggle in the fourth quarter with challenges in overseas markets, including the continued fallout from a recall that has damaged Abbott's baby-formula products in Asia and a weakened European economy that pressured sales of generic drugs.\n\nAbbott, which also makes medical devices and diagnostics, said sales rose 0.4% to $5.65 billion in the quarter from $5.63 billion in the year-earlier quarter. Net profit fell 44% to $589 million, or 37 cents a share, from $1.05 billion, or 66 cents a...", "article_metadata": {"article.template": "snippet", "article.created": "2014-01-22T13:19:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Abbott Laboratories said its fourth-quarter profit declined, hurt by the spinoff of its AbbVie business, but growth in other areas was solid.", "creator": "@joewalkerWSJ", "image": {"alt": "Abbott Labs profit falls 44%, hurt by impacts from AbbVie spinoff. $ABT", "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif"}, "title": "Abbott Labs Reports 44% Profit Decline", "site": "@WSJ", "card": "summary"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10001424052702303947904579336382486580134&headline=Abbott%20Labs%20profit%20falls%2044%25%2C%20hurt%20by%20impacts%20from%20AbbVie%20spinoff.%20%24ABT&weburl=http://www.wsj.com/articles/SB10001424052702303947904579336382486580134"}}, "page.site.product": "WSJ", "keywords": "abbott labs,abbvie spinoff,conference call,fonterra,growth stock,humira,miles white,recalls,Abbott%20Laboratories,ABT,performance,earnings,earnings projections,ownership changes,product safety,corporate actions,corporate,industrial news,product recalls,pharmaceuticals,health care,life sciences,medical research services,healthcare support services,medical,clinical,diagnostic services", "news_keywords": "abbott labs,abbvie spinoff,conference call,fonterra,growth stock,humira,miles white,recalls,Abbott%20Laboratories,ABT", "article.headline": "Abbott Labs profit falls 44%, hurt by impacts from AbbVie spinoff. $ABT", "description": "Abbott Laboratories said its fourth-quarter profit declined, hurt by the spinoff of its AbbVie business, but growth in other areas was solid.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10001424052702303947904579336382486580134&headline=Abbott%20Labs%20profit%20falls%2044%25%2C%20hurt%20by%20impacts%20from%20AbbVie%20spinoff.%20%24ABT&weburl=http://www.wsj.com/articles/SB10001424052702303947904579336382486580134", "user.type": "nonsubscriber", "article.page": "Business", "page.content.format": "responsive", "article.summary": "Abbott Laboratories said its fourth-quarter profit declined, hurt by the spinoff of its AbbVie business, but growth in other areas was solid.", "page.site": "wsj", "testkeys": "C", "article.published": "2014-01-22T17:53:00.000Z", "dj.asn": "i-f263", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"internal_link_count": 5, "embed_count": 1, "word_count": 559, "publisher": "https://www.facebook.com/wsj"}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Abbott Laboratories said its fourth-quarter profit declined, hurt by the spinoff of its AbbVie business, but growth in other areas was solid.", "title": "Abbott Labs Reports 44% Profit Decline", "url": "http://www.wsj.com/articles/SB10001424052702303947904579336382486580134", "image": {"width": 1200, "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "height": 630}, "locale": "en_US", "type": "article"}, "author": "Joseph Walker", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Abbott Labs Reports 44% Profit Decline", "article.type": "Earnings", "article.id": "SB10001424052702303947904579336382486580134", "user.exp": "default", "article.updated": "2014-01-22T17:53:00.000Z"}, "_id": "\"57477af36914bd0286fcfe25\"", "article_summary": "Net profit fell 44% to $589 million, or 37 cents a share, from $1.05 billion, or 66 cents a...\nAbbott, which also makes medical devices and diagnostics, said sales rose 0.4% to $5.65 billion in the quarter from $5.63 billion in the year-earlier quarter.\nAbbott Laboratories continued to struggle in the fourth quarter with challenges in overseas markets, including the continued fallout from a recall that has damaged Abbott's baby-formula products in Asia and a weakened European economy that pressured sales of generic drugs."}